People | July 11, 2022
Piramal Pharma strengthens board by inducting three new board members
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Govt committed to supporting pharma companies with industry-friendly policies
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Bringing next-gen cannabinoid therapeutics to cancer patients
Expanding diagnostics footprint in East India
Glenmark is the first company in India to market the innovative FDC of Indacaterol
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Subscribe To Our Newsletter & Stay Updated
